CHOICE Voice

A highlight of the Congress will be New York based artist Justine Cooper’s fictional marketing campaign for her magic-bullet lifestyle drug HAVIDOL which treats Dysphoric Social Attention Consumption Deficit Anxiety Disorder.

Cooper’s work – which will be displayed at Congress – is designed to call to task the unethical marketing and advertising tactics of the pharmaceutical industry. It consists of a package of material including TV ads, print ads, billboards, pill sculptures, merchandise and the HAVIDOL website.

To view one of the TV ads click here. Ms Cooper will also address the Congress, outlining why she undertook this project and its impact.

Presenter details
Justine Cooper, the creator of HAVIDOL, typically investigates the intersections between culture, science and medicine, moving between animation, video, web, installation, photography and medical imaging technologies such as MRI, DNA sequencing and Ultrasound. Her artwork has been internationally reviewed and exhibited. Most recently at the Asia-Pacific Triennial, Ars Electronica and Eyebeam, along with The New Museum, New York; The NTT InterCommunication Center, Tokyo; The Singapore Museum of Art; The Netherlands Institute for Media Art, The George Pompidou Centre, Paris; Kwang Ju Biennale, Korea, and the International Center of Photography, New York.

Her artwork is held in public and private collections including the Metropolitan Museum of Art, The Powerhouse Museum (Sydney), The Queensland Art Gallery and the Australian Center for the Moving Image. She was the recipient of an Australia Council Fellowship a 2-year, once in a lifetime prize awarded to an artist of outstanding artistic achievement and potential.